LABBOZZETTA, Manuela
 Distribuzione geografica
Continente #
NA - Nord America 6.292
EU - Europa 6.242
AS - Asia 3.239
SA - Sud America 511
AF - Africa 107
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
Totale 16.400
Nazione #
US - Stati Uniti d'America 6.182
IT - Italia 3.070
SG - Singapore 1.120
RU - Federazione Russa 930
CN - Cina 818
FI - Finlandia 501
BR - Brasile 407
UA - Ucraina 350
HK - Hong Kong 344
DE - Germania 323
VN - Vietnam 310
PL - Polonia 195
IE - Irlanda 180
FR - Francia 179
GB - Regno Unito 165
JP - Giappone 122
NL - Olanda 110
IN - India 105
SE - Svezia 82
TR - Turchia 82
BD - Bangladesh 58
CA - Canada 49
KR - Corea 49
MX - Messico 40
AR - Argentina 36
IR - Iran 33
IQ - Iraq 32
MY - Malesia 30
BE - Belgio 26
RO - Romania 23
ZA - Sudafrica 22
VE - Venezuela 21
MA - Marocco 20
PK - Pakistan 20
CI - Costa d'Avorio 19
BG - Bulgaria 18
ES - Italia 17
UZ - Uzbekistan 17
CH - Svizzera 16
AT - Austria 15
EG - Egitto 14
EC - Ecuador 13
ID - Indonesia 13
SA - Arabia Saudita 13
TN - Tunisia 12
AE - Emirati Arabi Uniti 9
LT - Lituania 9
CL - Cile 8
NP - Nepal 8
PH - Filippine 8
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
PY - Paraguay 6
SY - Repubblica araba siriana 6
BH - Bahrain 5
CO - Colombia 5
DZ - Algeria 5
EU - Europa 5
GR - Grecia 5
KZ - Kazakistan 5
LB - Libano 5
PE - Perù 5
UY - Uruguay 5
AL - Albania 4
HN - Honduras 4
MT - Malta 4
TW - Taiwan 4
AU - Australia 3
BO - Bolivia 3
GT - Guatemala 3
JM - Giamaica 3
JO - Giordania 3
NI - Nicaragua 3
SN - Senegal 3
TT - Trinidad e Tobago 3
BY - Bielorussia 2
DK - Danimarca 2
ET - Etiopia 2
GA - Gabon 2
GH - Ghana 2
GY - Guiana 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
LY - Libia 2
MM - Myanmar 2
MN - Mongolia 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GE - Georgia 1
KW - Kuwait 1
LK - Sri Lanka 1
MD - Moldavia 1
Totale 16.393
Città #
Ashburn 788
Singapore 736
Fairfield 532
Palermo 372
Chandler 340
Hong Kong 333
San Jose 325
Woodbridge 314
Houston 304
Ann Arbor 289
Wilmington 259
Seattle 201
Jacksonville 192
Cambridge 183
Dublin 174
Zgierz 165
Moscow 161
Beijing 145
Des Moines 137
Santa Clara 131
Medford 123
Milan 121
Tokyo 119
Rome 113
New York 111
Council Bluffs 109
Frankfurt am Main 108
Los Angeles 106
Ho Chi Minh City 104
Nanjing 87
The Dalles 81
Helsinki 76
Princeton 76
Dallas 75
Lauterbourg 75
Hanoi 74
Boardman 66
Hefei 55
Tulsa 51
Altamura 47
San Diego 47
Catania 45
Dearborn 42
Buffalo 41
São Paulo 41
Lawrence 37
Naples 37
Bologna 32
Venice 32
Izmir 31
Florence 30
Hebei 30
Verona 30
Shenyang 28
Brussels 23
Chicago 23
Nanchang 23
Atlanta 22
Memphis 22
Shanghai 22
Jinan 21
Messina 21
Changsha 20
London 20
Napoli 20
Abidjan 19
Bremen 19
Brooklyn 19
Ludwigshafen am Rhein 19
Columbus 18
Falls Church 18
Kuala Lumpur 18
Salerno 18
Orem 17
Rio de Janeiro 17
Denver 16
Warsaw 16
Jiaxing 15
Montreal 15
Munich 15
Ningbo 15
Nuremberg 15
Sofia 15
Turin 15
Amsterdam 14
Bari 14
Hangzhou 14
Auburn Hills 13
Brescia 13
Haiphong 13
Padova 13
Phoenix 13
Tashkent 13
Turku 13
Cagliari 12
Da Nang 12
Tianjin 12
Belo Horizonte 11
Capaci 11
Kumar 11
Totale 9.119
Nome #
ANALISI DEI POLIMORFISMI DEI GENI CODIFICANTI PER L'ENZIMA UDP-GLUCURONILTRANSFERASI (UGT) E PER L'ENZIMA DIIDROPIRIMIDINA DEIDROGENASI (DPD), CORRELATI A MAGGIORE TOSSICITA' IN SEGUITO A TRATTAMENTO, RISPETTIVAMENTE, CON IRINOTECANO E CON 5-FLUOROURACILE IN SOGGETTI CON TUMORE COLON RETTALE (CRC). 1.993
Curva da carico orale di metionina nella valutazione di pazienti affetti da patologia trombotica 653
Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells 292
Chemical and pharmaceutical evaluation of the relationship between triazole linkers and pore size on cyclodextrin–calixarene nanosponges used as carriers for natural drugs 278
Antitumor mechanism of the essential oils from two succulent plants in multidrug resistance leukemia cell 275
Chemical Composition, In Vitro Antitumor and Pro-Oxidant Activities of Glandora rosmarinifolia (Boraginaceae) Essential Oil 264
Induction of Apoptosis and Chemosensitization by the Histone Deacetylase Inhibitor Trichostatin in Hepatocellular Carcinoma Cells: Molecular Analysis and RKIP Levels 252
Analysis of Possible Mechanisms Accounting for Raf-1 Kinase Inhibitor Protein Downregulation in Hepatocellular Carcinoma 248
"Antitumor effects of the novel NF-kB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production”. 246
Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer 242
Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma 241
Epigenetic changes and nuclear factor-κB activation, but not microRNA-224, downregulate Raf-1 kinase inhibitor protein in triple‑negative breast cancer SUM 159 cells 241
Essential oil of Cyphostemma juttae (Vitaceae): chemical composition and antitumor mechanism in triple negative breast cancer cells 241
Yin Yang 1 and Raf-1 Kinase Inhibitory Protein Status in Hepatocellular Carcinoma: Future Perspectives 232
Analisi dei polimorfismi dei geni codificanti per l’enzima UDP-glucuronosiltrasferasi (UGT) e per l’enzima diidropirimidina deidrogenasi (DPD), correlati a maggiore tossicità in seguito a trattamento, rispettivamente, con Irinotecano e con 5-Fluorouracile in soggetti con tumore colon rettale (CRC) 230
The antitumor activities of curcumin and its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 brest cancer cell line: Analysis of the possible molecular basis. 225
Alteration of signaling pathways in hepatocellular carcinoma: identification of new pharmacological targets and possible prognosis markers. 213
Effetti della curcumina e di suoi analoghi modificati al frammento beta-dichetone in cellule tumorali multifarmacoresistenti. 209
Pro-oxidant and antitumor effects of curcumin and N-ethylmaleimide in the HA22T/VGH model Overt hepatocellular carcinoma. 209
Meccanismi antitumorali degli oli essenziali estratti da piante succulente in un modello di leucemia mielocitica acuta multifarmacoresistente 206
Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells 205
Cytotoxicity of oleanolic and ursolic acid derivatives toward hepatocellular carcinoma and evaluation of NF-κB involvement 204
Frequent alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein ratio in hepatocellular carcinoma 202
Can NF-κB Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of View 195
Essential Oil Composition of Alluaudia procera and in Vitro Biological Activity on Two Drug-Resistant Models 194
Mechanisms of Raf-1 Kinase Inhibitor Protein Dysregulation in Triple-Negative Breast Cancers and Identification of Possible Novel Therapeutic Approaches for These Tumors 192
Analysis of UGT1A1*28 and DPYD*2A polymorphisms in Sicilians patients with metastatic colorectal cancer treated with Irinotecan and 5-fluorouracil. 185
Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of β-catenin and inhibition of β-catenin-mediated transactivation 184
Unusual high dose of tacrolimus in liver transplant patient, a case report. 183
Antitumor effects of the NF-kB inhibitors curcumin and DHMEQ, alone or combined with cisplatin, on hepatic cancer cells. analysis of their relationship to IL-6 production. 182
Citrus wastewater as a source of value‐added products: Quali‐quantitative analysis and in vitro screening on breast cancer cell lines 181
Antitumor effects of the grape stilbenes resveratrol and piceatannol on multidrug and apoptosis resistant HL60 leukemia cells" 180
The NF-kB inhibitors curcumin and DHMEQ exert antitumor synergy with cisplatin in hepatic cancer cells. Analysis of relationship to IL-6 production. 176
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients 176
Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients. 175
Antitumor effects of curcumin, alone or in combination with cisplatin, on hepatic cancer cells. Analysis of their relationship to IL-6 production 174
Antitumor effects of curcumin in human hepatic cancer cells: Analysis of their relationship to inhibition of NF-kB and pro-survival gene expression. 172
Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients 168
Plant polyphenols as possible lead compound against hormone-independent multidrug resistant breast cancer. 167
“Antitumor and molecular effects of curcumin and of its isoxazole analogue on multidrug resistant breast cancer cells. New perspectives in tumor theraphy: molecular aspects, 2006”. 165
null 164
Lack of nucleophilic addition in the isoxazole and pyrazole diketone modified analogs of curcumin; implications for their antitumor and chemosensitizing activities. 163
Phytol and heptacosane: the two major components of Euphorbia intisy essential oil with biological activities in drug resistant leukemia cell. 163
Synthesis of Curcumin Derivatives and Analysis of Their Antitumor Effects in Triple Negative Breast Cancer (TNBC) Cell Lines 162
Evaluation of patients with thrombotic stroke by methionine loading oral curve 161
Analysis of pharmacologic approaches able to restore RKIP function in hepatocellular carcinoma 160
NF-kB Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers 160
Induction of apoptosis by the adenosine derivative IB-MECA in parental or multidrug-resistant HL-60 leukemia cells: possibile relationship to the effects on inhibitor of apoptosis protein levels 159
Evaluations and new relationships between renal failure and homocysteine plasma levels in patients with chronic renal failure 156
Le attività antitumorali della curcumina e del suo più potente analogo isossazolico non sono compromesse dal pattern di espressione genica della variante MDR della linea di carcinoma mammario MCF-7 154
In Vitro Modulation of P-Glycoprotein Activity by Euphorbia intisy Essential Oil on Acute Myeloid Leukemia Cell Line HL-60R 154
Antitumor Effect of Glandora rosmarinifolia (Boraginaceae) Essential Oil through Inhibition of the Activity of the Topo II Enzyme in Acute Myeloid Leukemia 153
DISTRIBUTION OF CYP3A5 AND MDR-1 SINGLE NUCLEOTIDE POLYMORPHISMS IN CAUCASIAN LIVER TRANSPLANT PATIENTS 152
Evaluations and new relationship between renal failure and homocysteine plasma levels in patients with chronic renal failure. 152
Significance of Autologous Interleukin-6 Production in the HA22T/VGH Cell Model of Hepatocellular Carcinoma 152
PLLA Porous Scaffold as a 3D Breast Cancer Model to Investigate Drug Resistance 146
Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver Carcinoma 146
Plasma homocysteine levels in patients with chronic renal failure 142
Effetti della curcumina e del suo derivato isossazolico in modelli di neoplasia multifarmacoresistente 140
The antitumor activities of curcumin and of its novel isoxazole analogue MR 39 are not hampered by the multidrug resistant condition of tumor cells expressing both P-glycoprotein and different inhibitory of apoptosis proteins 140
Rash and multiorgan dysfunction following lamotrigine: could genetic be involved? 140
Alteration of the YY1/RKIP ratio is a frequent event in hepatocellular carcinoma 140
NF-κB is a potential pharmacological target in triple negative breast cancers. 135
ELABORATION OF CURCUMIN INTO DIKETONE MODIFIED ANALOGUES DEVOID OF NUCLEOPHILIC ADDITION CAPABILITY; IMPLICATIONS FOR THEIR ANTITUMOR AND CHEMOSENSITIZING ACTIVITIES 132
Natural Inhibitors of P-glycoprotein in AcuteMyeloid Leukemia 131
Effects of curcumin and related analogues on tumor cell lines expressing multiple mechanisms of drug resistance 129
Plasma homocysteine levels in patients with chronic renal failure. 129
Potential role of the natural multi-targeted agent curcumin in the treatment of oral diseases. 127
Possible mechanisms of Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma 123
New trends in overcoming drug resistance in hepatocellular carcinoma. Looking for pharmacological inhibition of Inhibitory of Apoptosis Proteins (IAPs) by curcumin. 122
THE EFFECT OF CYP3A5 AND ABCB1 SINGLE NUCLEOTIDE POLYMORPHISMS ON TACROLIMUS DOSE REQUIREMENTS IN CAUCASIAN LIVER TRANSPLANT PATIENTS 122
Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid Leukemia 118
Antimigratory effects of a new NF-κB inhibitor, (S)-b-salicyloylamino-a-exo-methylene-ƴ-butyrolactone, in 2D and 3D breast cancer models 117
Plasma omocysteine levels in patients with chronic renal failure 117
Design and synthesis of hybrid drugs based on curcumin scaffold 117
Expression of a specific Thymidylate synthase polimorfic allele in metastatic colorectal patients is regulated by Myeloid Zinc Finger 1. 117
Vesicle-Transported Multidrug Resistance as a Possible Therapeutic Target of Natural Compounds 115
Effects of the dietary polyphenols resveratrol and curcumin on the prevention and treatment of cancer. 115
Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma: investigation of possible mechanisms 115
Restoration of Raf-1 Kinase Inhibitor Protein levels as a possible therapeutic approach in hepatocellular carcinoma. 110
Novel insights on [1,2]oxazolo[5,4‐e]isoindoles on multidrug resistant acute myeloid leukemia cell line 107
Synthesis, In Vitro and In Silico Analysis of New Oleanolic Acid and Lupeol Derivatives against Leukemia Cell Lines: Involvement of the NF-κB Pathway 106
Epigenetic and Cellular Reprogramming of Doxorubicin-Resistant MCF-7 Cells Treated with Curcumin 100
MDA-9/Syntenin-NF-κB-RKIP loop in triple negative breast cancers (TNBC) and human liver carcinoma 87
Patterns of Innate or Acquired Resistance to Anticancer Drugs: Our Experience to Overcome It 71
null 67
Altered Yin Yang 1/RAF-1 kinase inhibitory protein ratio as a possible molecular marker and therapeutic target in hepatocellular carcinoma 31
Totale 16.769
Categoria #
all - tutte 48.745
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.745


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202195 0 0 0 0 0 0 0 0 0 0 0 95
2021/20221.086 65 220 32 32 52 32 66 45 95 183 61 203
2022/20231.289 128 157 16 133 140 192 113 88 131 29 99 63
2023/20241.424 74 113 142 92 95 185 170 106 45 139 96 167
2024/20252.380 107 201 175 235 167 115 173 140 190 229 271 377
2025/20265.551 403 197 322 436 514 862 774 551 411 829 233 19
Totale 16.769